Dataset from A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Subjects With Type 2 Diabetes
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接:
https://doi.org/10.25934/00002495
下载链接
链接失效反馈官方服务:
资源简介:
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), compared to glipizide in elderly diabetic patients who have not received treatment or are on a single oral medication.
创建时间:
2025-12-08



